MoneyWorks4Me

WHO-Geneva inspects Unit-2 facility of Mangalam Drugs & Organics

18 Feb 2017 Evaluate

Mangalam Drugs & Organics’ facility at Unit-2 has been inspected by WHO-Geneva and the authority has issued few procedural observations. The company shall respond to the same within stipulated time after the receipt of Audit Report. The company believes that the audit was successful.

Mangalam Drugs & Organics is a part of the MangalamGroup, manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..